Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Pharmaceuticals ETF (XPH) and SPDR S&P Health Care Services ETF (XHS) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. Both XPH and XHS have the same Total Expense Ratio (TER) of 0.35%. XPH is down -1.12% year-to-date (YTD) with +$88M in YTD flows. XHS performs worse with -1.75% YTD performance, and +$6M in YTD flows. Run a side-by-side ETF comparison of XPH and XHS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XPH XHS | -3.45%-3.11% | -1.36%-3.76% | -1.12%-1.75% | +29.22%+10.69% | +42.98%+26.75% | +9.16%-0.05% |
| Flows | XPH XHS | +$12M-$8M | +$95M+$2M | +$88M+$6M | +$111M-$3M | +$48M-$34M | +$36M-$36M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XPH XHS | +20.33%+17.45% | +23.08%+19.20% | +19.01%+18.15% | +20.26%+21.12% |
| Max drawdown | XPH XHS | -5.97%-6.02% | -17.10%-12.54% | -23.45%-17.78% | -33.10%-32.53% |
| Max drawdown duration | XPH XHS | 14d64d | 140d128d | 322d362d | 1706d1717d |
XPH | XHS | |
Last sale 3/12/2026 at 1:34 PM | $54.05 | $104.90 |
| Previous close 03/11/2026 | $55.49 | $105.14 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XPH | XHS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XPH | XHS | |
|---|---|---|
| Last price | $54.05 | $104.90 |
| 1D performance | -2.60% | -0.23% |
| AuM | $313.37 M | $87.16 M |
| E/R | 0.35% | 0.35% |
XPH | XHS | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | SPDR | SPDR |
| Benchmark | S&P Pharmaceuticals Select Industry Index | S&P Health Care Services Select Industry Index |
| N° of holdings | 49 | 52 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | September 28, 2011 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
